Vectura Group plc is a product development company focused on the development of a range of inhaled therapies, principally for the treatment of respiratory diseases. Our goal is to improve patients’ lives and generate value for our stakeholders.
Press releases
29 June 2009Vectura and Sosei announce start of Phase III clinical study with NVA237
19 May 2009Vectura Group plc - Preliminary Results
12 May 2009Date of announcement of Preliminary Results for year ended 31 March 2009
Latest press releases
Next events
14-16 Sept 2009European Respiratory Society Meeting, Vienna
Investor Calendar
